Protagenic TherapeuticsPTIX
13F holders, Q2 2025 (June 30)11holders
$3.65avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Protagenic Therapeutics Inc. (PTIX) in their 13F filings. The largest holders were Virtu Financial LLC ($69K), Alpine Global Management, LLC ($60K) and Morgan Stanley ($55K).
- Company
- Protagenic Therapeutics Inc.
- CUSIP
- 74365N301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $258K |
| Exits | 0 | $0 |
Ownership 11 holders
| Virtu Financial LLC | 0.00% | New | 18,808 | $69K |
| Alpine Global Management, LLC | 0.02% | New | 16,351 | $60K |
| Morgan Stanley | 0.00% | New | 15,002 | $55K |
| Susquehanna International Group, LLP | 0.00% | New | 10,156 | $37K |
| UBS Group AG | 0.00% | New | 9,020 | $33K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 876 | $3K |
| Citigroup Inc. | 0.00% | New | 390 | $1K |
| Bank of America Corp. | 0.00% | New | 6 | $23 |
| Raymond James Financial Inc. | 0.00% | New | 1 | $4 |
| Harbor Investment Advisory, LLC | 0.00% | New | 1 | $4 |
| Cwm, LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is PTIX's weight in each manager's 13F, not the share of Protagenic Therapeutics Inc. the manager owns.